Cancers | Free Full-Text | Disulfiram as a Therapeutic Agent for Metastatic Malignant Melanoma—Old Myth or New Logos?
Targeting EMT in Cancer with Repurposed Metabolic Inhibitors: Trends in Cancer
Cancers | Free Full-Text | Disulfiram as a Therapeutic Agent for Metastatic Malignant Melanoma—Old Myth or New Logos?
Disulfiram: a novel repurposed drug for cancer therapy | SpringerLink
Diethyldithiocarbamate-copper complex (CuET) inhibits colorectal cancer progression via miR-16-5p and 15b-5p/ALDH1A3/PKM2 axis-mediated aerobic glycolysis pathway | Oncogenesis
Disulfiram targets cancer stem-like cells and reverses resistance and cross-resistance in acquired paclitaxel-resistant triple-negative breast cancer cells | British Journal of Cancer
Regulated cell death (RCD) in cancer: key pathways and targeted therapies | Signal Transduction and Targeted Therapy
Disulfiram's anti-cancer activity reflects targeting NPL4, not inhibition of aldehyde dehydrogenase | Oncogene
Disulfiram-loaded functionalized magnetic nanoparticles combined with copper and sodium nitroprusside in breast cancer cells - ScienceDirect
Cytotoxic effect of disulfiram/copper on human glioblastoma cell lines and ALDH-positive cancer-stem-like cells | British Journal of Cancer
Disulfiram's anti-cancer activity reflects targeting NPL4, not inhibition of aldehyde dehydrogenase | Oncogene
Disulfiram and copper combination therapy targets NPL4, cancer stem cells and extends survival in a medulloblastoma model | PLOS ONE
Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4 | Nature
Frontiers | Recent Advances in Repurposing Disulfiram and Disulfiram Derivatives as Copper-Dependent Anticancer Agents
The anti-alcohol dependency drug disulfiram inhibits the viability and progression of gastric cancer cells by regulating the Wnt and NF-κB pathways - Jun Zhang, Ke Pu, Suyang Bai, Yukui Peng, Fan Li,
Enhanced Tumor-Specific Disulfiram Chemotherapy by In Situ Cu2+ Chelation-Initiated Nontoxicity-to-Toxicity Transition | Journal of the American Chemical Society
Frontiers | The Disulfiram/Copper Complex Induces Autophagic Cell Death in Colorectal Cancer by Targeting ULK1
Targeting FROUNT with disulfiram suppresses macrophage accumulation and its tumor-promoting properties | Nature Communications
Disulfiram modulated ROS–MAPK and NFκB pathways and targeted breast cancer cells with cancer stem cell-like properties | British Journal of Cancer
Potential therapeutic targets for disulfiram in a cancer cell.... | Download Scientific Diagram
Double trouble: A drug for alcoholism can also treat cancer by targeting macrophages | Tokyo University of Science
Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4 | Nature
Disulfiram and BKM120 in Combination with Chemotherapy Impede Tumor Progression and Delay Tumor Recurrence in Tumor Initiating Cell-Rich TNBC | Scientific Reports
Disulfiram and copper combination therapy targets NPL4, cancer stem cells and extends survival in a medulloblastoma model | PLOS ONE
The combination of disulfiram and copper for cancer treatment - ScienceDirect
